Statement Of Comprehensive Income [Abstract]

ERYTECH Pharma S.A. - Filing #2813524

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	228,000 EUR	—	228,000 EUR	—	—	53 797 EUR	—	—	—	—	53 797 EUR	—	73 300 EUR	—	—	73 300 EUR	—
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, before tax [abstract]
Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans	—	—	—	235,000 EUR	—	—	—	—	—	—	—	68,000 EUR	—	19,000 EUR	—	—	—	—
Components of other comprehensive income that will be reclassified to profit or loss, before tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations	—	—	—	187,000 EUR	—	—	—	—	—	—	—	528,000 EUR	—	400,000 EUR	—	—	—	—
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss	—	—	—	— EUR	—	—	—	—	—	—	—	— EUR	—	— EUR	—	—	—	—
Other comprehensive income	235,000 EUR	EUR	—	422,000 EUR	—	187,000 EUR	—	68,000 EUR	—	—	528,000 EUR	460,000 EUR	—	381,000 EUR	400,000 EUR	—	—	19,000 EUR
Comprehensive income	235,000 EUR	228,000 EUR	— EUR	194,000 EUR	— EUR	187,000 EUR	53 797 EUR	68,000 EUR	— EUR	— EUR	528,000 EUR	54 257 EUR	— EUR	72 919 EUR	400,000 EUR	— EUR	73 300 EUR	19,000 EUR